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PERSISTENT EFFECTS OF BINGE DRINKING ON ADOLESCENT BRAIN

S26.1 EFFECTS OF ADOLESCENT ETHANOL EXPOSURE ON BRAIN SYNCHRONY, BEHAVIOR, DTI VOLUMES, NEUROGENESIS AND CHOLINE ACETYL TRANSFERASE C. Ehlers and F. Crews
The Scripps Research Institute, La Jolla, CA, United States Background. Epidemiological data indicate that excessive alcohol consumption is prevalent among adolescents and may have lasting neurobehavioral consequences. Animal models provide the control necessary to investigate the potentially neurotoxic effects of alcohol on adolescent brain development. Methods. Wistar rats were exposed to ethanol vapor/air control 14 hrs/day for 35 days from P22-P57 (average BAC 163 mg%). Rats were withdrawn from vapor for 2-8 weeks and assessed for: electrophysiology, disinhibition, startle response and swim responses as adults. Rats were sacrificed at either day 72 or day 127 and either perfused for MRI and histochemical analyses (measures of neurogenesis, ChAT).
Results. Alcohol exposed rats displayed a significant reduction in the amplitude of their responses to prepulse stimuli during the startle paradigm, reduced energy and phase locking of ERO gamma activity, disinhibition in the open field conflict and decreased latency to immobility in the swim test. Volumetric analyses of MRI data indicated a reduction in the size of the hippocampus and an increase in the size of the ventricles in the ethanol exposed animals.
Measures of neurogenesis were reduced in hippocampus and measures of ChAT were reduced in the basal forbrain in the ethanol exposed animals. Behavioral measures were found to correlate with structural brain findings.
Conclusions. Adolescent alcohol binge drinking constitutes a major vulnerability factor to develop alcoholism. However, mechanisms underlying this susceptibility remain unknown. We evaluated the effect of adolescent binge-like ethanol intoxication on vulnerability to alcohol abuse in Sprague-Dawley rats. To model binge-like ethanol intoxication, every 2 days, rats received an ethanol injection (3.0 g/kg) for 2 consecutive days across 14 days either from postnatal day 30 (PND30) to 43 (early adolescence) or from PND 45 to PND 58 (late adolescence), as first described by the Consuelo Guerri's group. In young adult animals, we measured free ethanol consumption in the two-bottle choice paradigm, motivation for ethanol in the operant self-administration task and both ethanol's rewarding and aversive properties in the conditioned place preference (CPP) and taste aversion (CTA) paradigms. While intermittent ethanol intoxications (IEI) during late adolescence had no effect on free-choice 10% ethanol consumption, we found that IEI during early adolescence promoted free-choice 10% ethanol consumption, enhanced motivation for ethanol in the self-administration paradigm and induced a loss of both ethanol-induced CPP and CTA in young adults. No modification in either sucrose selfadministration or amphetamine-induced CPP was observed. IEI exposure during early adolescence also increased basal levels of anxiety-like behaviour. As the nucleus accumbens (Nac) is particularly involved in addictive behaviour, we analysed IEI-induced long-term neuroadaptations in the Nac using c-Fos immunohistochemistry and an array of neurotransmission-related genes. This vulnerability to ethanol abuse was associated with a lower c-Fos immunoreactivity in the Nac and enduring alterations of the expression of Penk and Slc6a4, 2 neurotransmission-related genes that have been shown to play critical roles in the behavioural effects of ethanol and alcoholism. This work was supported by the European project AlcoBinge from the INTERREG IVA programme. Ingestion of alcohol leads to substantial variability across subjects in the systemic exposure to alcohol, including that of the brain. Using intravenous infusion bypasses these sources of variability and, together with a physiologically based pharmacokinetic (PBPK) model of alcohol distribution and elimination grants much better control over the time course of arterial blood alcohol concentration (aBAC). Infusion rates are adapted once every 30 seconds to follow an aBAC time profile prescribed by the experimenter. Besides improved control over aBAC, other advantages of i.v. alcohol administration over oral ingestion include safety, since aBAC declines immediately after the infusion is stopped and blinding, since alcohol can be administered without the subject's awareness. Infusion also provides a reliable method for dissociating the response to alcohol administration from demand characteristics such as taste, smell, and familiarity/ preference of the source of the alcohol. Initially, these methods were developed to achieve constant aBAC over several hours of experiments testing alcohol effects ("alcohol clamping"). With more refined methods of modeling, infusion was recently developed for self-administration experiments with free access or operant paradigms requiring work to gain access to alcohol. Results of two selfadministration studies will be presented. The computer-assisted infusion system (CAIS), i.e. a software platform enabling for all these types of experiments is now made available to interested researchers. Computer-Assisted Self-infusion of Ethanol (CASE) is a method of intravenous (IV) alcohol administration that allows alcohol self-administration in a laboratory setting, while controlling the breath alcohol concentration (BrAC) using a physiologically-based pharmacokinetic (PBPK) model-based algorithm. The objective of this study was to develop and characterize operant IV alcohol selfadministration in non-dependent drinkers using two paradigms: free-access and progressive-ratio. Healthy non-dependent drinkers completed two IV alcohol self-administration sessions, each consisting of a 25-min priming phase followed by a 125-min phase where they could push a button for additional ethanol infusions, using a free-access (FA) schedule (one button press/ infusion) and a progressive ratio (PR) schedule (increasing button presses for infusions). The number of rewards and peak and average BrAC were recorded, as well as the total and average number of button presses and button-press rate for the PR group. Regression analyses assessed effects of drinking history, alcohol sensitivity and personality. Results indicated high degree of within-session correlation among self-administration measures for both paradigms, indicating high internal consistency. In the FA paradigm, self-administration measures were significantly associated with drinks/drinking day, alcohol sensitivity, and reward sensitivity. Alcohol urges following priming were associated with self-administration measures for both OB and PR paradigms and rates of self-infusion were associated with subjective response to alcohol and measures of expectancy and impulsivity. Individuals with higher expectancy of negative alcohol effects and with higher impulsivity showed lower responses on both paradigms. These results indicate that IV self-administration measures reflect drinking history and alcohol sensitivity and expectancy effects. For example, human studies with alcohol-dependent individuals suggest that higher blood levels of the orexigenic gut-brain peptide ghrelin are associated with higher selfreported alcohol craving. Our most recent longitudinal study indicated a significant difference in baseline ghrelin levels between non-abstinent and abstinent subjects, as well as inverse ghrelin's patterns between the two groups during the study. Furthermore, there was a positive significant correlation between baseline ghrelin levels and self-reported alcohol craving. More recently, we performed a human laboratory study in non-treatment seeking heavy drinking alcohol-dependent individuals where subjects are randomized to receive an intravenous (IV) administration of ghrelin 1 microg/kg, 3 microg/ kg or saline solution ( placebo). Then, subjects undertake an alcohol cue-reactivity session to assess cue-induced urge to drink, as well as other subjective (e.g. attention to cues) and physiological (heart rate, salivation) measurements of alcohol cue-elicited craving. In this study, administration IV of ghrelin resulted in acute increase in craving (cue-induced urge to drink). Altogether, these data suggest that the ghrelin system may represent a novel pharmacological target to treat patients with alcoholism. Subjective responses to alcohol represent biomarkers of alcoholism liability and treatment response. This study aimed to integrate the human laboratory with neuroimaging by testing whether subjective responses to alcohol during alcohol administration predict neural responses to alcohol cues in the scanner. Study design included a within-subjects controlled alcohol administration in the laboratory followed by an alcohol taste cues blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI) task. Twenty alcohol dependent individuals from the Los Angeles community were recruited (6 females; 90% Caucasian; mean age = 29.4). Laboratory assessments of subjective alcohol high, liking, wanting (i.e., craving), positive reinforcement, and negative reinforcement during alcohol administration were entered as predictors of neural response to the presentation of alcohol versus control cues in the scanner (whole-brain cluster-corrected at Z > 1.96, p < 0.05). Alcohol craving during alcohol administration was found to predict less neural activity to alcohol cues in regions including the precentral and postcentral gyri, and supplementary motor area. Alcohol high, however, predicted greater neural activity to alcohol cues in regions including the anterior cingulate cortex, angular gyrus, occipital cortex, and superior parietal lobule. Consistent results were observed across the reinforcement factors such that greater positive and negative reinforcement in the lab predicted greater activation during alcohol cue presentation in regions including the precuneus, anterior cingulate cortex, and cuneal cortex. This study provides initial evidence that subjective
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